A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial
Hagman, Helga LU
; Frödin, Jan-Erik
; Berglund, Åke
; Sundberg, Jan
; Vestermark, Lene
; Albertsson, Maria
; Fernebro, Eva
LU
and Johnsson, Anders
LU
(2016)
In Annals of Oncology
27(1).
p.140-147
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/ec3e1c14-a029-4ba0-8444-6f6421ef4074
- author
- Hagman, Helga
LU
; Frödin, Jan-Erik
; Berglund, Åke
; Sundberg, Jan
; Vestermark, Lene
; Albertsson, Maria
; Fernebro, Eva
LU
and Johnsson, Anders
LU
- publishing date
- 2016-01
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Annals of Oncology
- volume
- 27
- issue
- 1
- pages
- 140 - 147
- publisher
- Oxford University Press
- external identifiers
-
- scopus:84960127748
- pmid:26483047
- ISSN
- 1569-8041
- DOI
- 10.1093/annonc/mdv490
- language
- English
- LU publication?
- no
- id
- ec3e1c14-a029-4ba0-8444-6f6421ef4074
- date added to LUP
- 2017-04-12 16:18:10
- date last changed
- 2025-10-14 13:10:19
@article{ec3e1c14-a029-4ba0-8444-6f6421ef4074,
author = {{Hagman, Helga and Frödin, Jan-Erik and Berglund, Åke and Sundberg, Jan and Vestermark, Lene and Albertsson, Maria and Fernebro, Eva and Johnsson, Anders}},
issn = {{1569-8041}},
language = {{eng}},
number = {{1}},
pages = {{140--147}},
publisher = {{Oxford University Press}},
series = {{Annals of Oncology}},
title = {{A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial}},
url = {{http://dx.doi.org/10.1093/annonc/mdv490}},
doi = {{10.1093/annonc/mdv490}},
volume = {{27}},
year = {{2016}},
}